Evonik Industries/€EVK
Evonik falls 3.5% after Ifo survey showed German chemical industry sentiment plunged to lowest in over 30 years on weak orders and intensifying competition.
17 hours agoLightyear AI
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Evonik Industries
Evonik Industries AG, a German multinational, specializes in producing specialty chemicals, primarily focusing on consumer goods, animal nutrition, and pharmaceuticals. Founded in 1873, the company operates globally and is structured into multiple segments including Specialty Additives, Nutrition & Care, and Smart Materials among others. As a publicly traded entity, it is listed on the Frankfurt Stock Exchange under the ticker EVK.
Ticker
€EVK
Sector
Primary listing
XETRA
Employees
31,297
Headquarters
Website
EVK Metrics
BasicAdvanced
€6.6B
69.30
€0.20
0.73
€1.17
8.26%
Price and volume
Market cap
€6.6B
Beta
0.73
52-week high
€22.39
52-week low
€13.87
Average daily volume
165K
Dividend rate
€1.17
Financial strength
Current ratio
1.539
Quick ratio
0.615
Long term debt to equity
41.388
Total debt to equity
53.405
Dividend payout ratio (TTM)
573.68%
Interest coverage (TTM)
3.13%
Profitability
EBITDA (TTM)
1,553
Gross margin (TTM)
23.76%
Net profit margin (TTM)
0.67%
Operating margin (TTM)
2.98%
Effective tax rate (TTM)
58.94%
Revenue per employee (TTM)
€460,000
Management effectiveness
Return on assets (TTM)
2.24%
Return on equity (TTM)
1.23%
Valuation
Price to earnings (TTM)
69.295
Price to revenue (TTM)
0.461
Price to book
0.78
Price to tangible book (TTM)
2.02
Price to free cash flow (TTM)
14.436
Free cash flow yield (TTM)
6.93%
Free cash flow per share (TTM)
0.981
Dividend yield (TTM)
8.26%
Forward dividend yield
8.26%
Growth
Revenue change (TTM)
-5.92%
Earnings per share change (TTM)
-58.34%
3-year revenue growth (CAGR)
-7.86%
10-year revenue growth (CAGR)
0.53%
3-year earnings per share growth (CAGR)
-53.26%
10-year earnings per share growth (CAGR)
-21.08%
10-year dividend per share growth (CAGR)
1.58%
What the Analysts think about EVK
Analyst ratings (Buy, Hold, Sell) for Evonik Industries stock.
Bulls say / Bears say
Evonik’s first-quarter 2025 adjusted EBITDA climbed 7 percent to €560 million, surpassing analyst expectations of €543 million, and grew its margin to 14.8 percent, driven by strong performance in Nutrition & Care and tight cost management (Reuters)
At its May 2025 Capital Markets Day, Evonik introduced a strategic framework aimed at adding €1 billion to core EBITDA by 2027, split equally between internal growth and cost savings, in order to achieve an 11 percent return on capital employed (Reuters)
Investor sentiment remains positive, with Evonik’s share price nearly 20 percent higher year-to-date following its resilient first-quarter results and the confirmation of guidance (Reuters)
Evonik lowered its 2025 core profit guidance to around €1.9 billion, below its previous €2.0–2.3 billion range and the median analyst estimate of €1.96 billion, citing ongoing weak demand. This marks the second downward revision in recent months (Reuters)
In the second quarter of 2025, Evonik’s core profit dropped 12 percent year-over-year to €509 million, missing the analyst consensus of €511 million and pointing to continued demand challenges across its segments (Reuters)
The abrupt resignation of CFO Maike Schuh after the profit-guidance cut raises concerns about execution risk, especially as the company undertakes its largest-ever restructuring (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 11 Nov 2025.
EVK Financial Performance
Revenues and expenses
EVK Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Evonik Industries stock?
Evonik Industries (EVK) has a market cap of €6.6B as of November 12, 2025.
What is the P/E ratio for Evonik Industries stock?
The price to earnings (P/E) ratio for Evonik Industries (EVK) stock is 69.3 as of November 12, 2025.
Does Evonik Industries stock pay dividends?
Yes, the Evonik Industries (EVK) stock pays dividends to shareholders. As of November 12, 2025, the dividend rate is €1.17 and the yield is 8.26%. Evonik Industries has a payout ratio of 573.68% on a trailing twelve-month basis.
When is the next Evonik Industries dividend payment date?
The next Evonik Industries (EVK) dividend payment date is unconfirmed.
What is the beta indicator for Evonik Industries?
Evonik Industries (EVK) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.